Literature DB >> 22994307

Application of umbilical cord serum eyedrops after laser epithelial keratomileusis.

Kyung-Chul Yoon1, Han-Jin Oh, Jung-Won Park, Jin Choi.   

Abstract

PURPOSE: To investigate the efficacy of umbilical cord serum eyedrops after laser epithelial keratomileusis (LASEK).
METHODS: Sixty patients (120 eyes) with myopia who underwent LASEK were studied. Thirty-two patients (64 eyes) were treated with 20% umbilical cord serum eyedrops in combination with conventional treatment (group A), and 28 patients (56 eyes) received conventional treatment only (group B). Epithelial healing time was analysed. Visual acuity, refraction, haze score (0-4) and tear film and ocular surface parameters were evaluated at 1, 2, 4 and 12 weeks after LASEK. The concentration of transforming growth factor (TGF)-β1 in tears was measured with ELISA at 1 week after LASEK.
RESULTS: No significant differences in visual acuity and refraction were found between groups. The mean time to epithelial healing was 3.53 ± 1.19 days in group A and 3.91 ± 1.41 days in group B (p = 0.18). The mean haze scores at 2 and 4 weeks were 0.59 ± 0.80 and 0.31 ± 0.54 in group A and 1.06 ± 0.91 (p = 0.02) and 0.69 ± 0.78 (p = 0.03) in group B. Four and 12 weeks after LASEK, tear film break-up time was longer and keratoepitheliopathy score was lower in group A compared with group B. The mean concentration of TGF-β1 was lower in group A compared with group B (p = 0.01).
CONCLUSION: Application of 20% umbilical cord serum eyedrops in addition to conventional treatment after LASEK can reduce early postoperative corneal haze and improve tear film and ocular surface parameters.
© 2012 The Authors. Acta Ophthalmologica © 2012 Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994307     DOI: 10.1111/j.1755-3768.2012.02538.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  8 in total

1.  Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.

Authors:  Umut Arslan; Emin Özmert; Sibel Demirel; Firdevs Örnek; Figen Şermet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-15       Impact factor: 3.117

2.  Plasma Rich in Growth Factors (PRGF) in Transepithelial Photorefractive Keratectomy (TPRK).

Authors:  José-María Sánchez-González; Federico Alonso-Aliste; Davide Borroni; Jonatan Amián-Cordero; Concepción De-Hita-Cantalejo; Raúl Capote-Puente; María-José Bautista-Llamas; María Carmen Sánchez-González; Marina Rodríguez-Calvo-de-Mora; Carlos Rocha-de-Lossada
Journal:  J Clin Med       Date:  2021-04-30       Impact factor: 4.241

Review 3.  Use of umbilical cord serum in ophthalmology.

Authors:  Kyung Chul Yoon
Journal:  Chonnam Med J       Date:  2014-12-17

Review 4.  Application of Novel Drugs for Corneal Cell Regeneration.

Authors:  Sang Beom Han; Yu-Chi Liu; Karim Mohamed-Noriega; Jodhbir S Mehta
Journal:  J Ophthalmol       Date:  2018-05-02       Impact factor: 1.909

Review 5.  Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus.

Authors:  Federico Bernabei; Matilde Roda; Marina Buzzi; Marco Pellegrini; Giuseppe Giannaccare; Piera Versura
Journal:  J Clin Med       Date:  2019-09-17       Impact factor: 4.241

Review 6.  Use of Acellular Umbilical Cord-Derived Tissues in Corneal and Ocular Surface Diseases.

Authors:  Arianna A Tovar; Ian A White; Alfonso L Sabater
Journal:  Medicines (Basel)       Date:  2021-02-09

Review 7.  Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis.

Authors:  Maria Rosaria De Pascale; Michele Lanza; Linda Sommese; Claudio Napoli
Journal:  J Ophthalmol       Date:  2015-10-04       Impact factor: 1.909

Review 8.  Umbilical Cord Blood and Serum for the Treatment of Ocular Diseases: A Comprehensive Review.

Authors:  Giuseppe Giannaccare; Adriano Carnevali; Carlotta Senni; Laura Logozzo; Vincenzo Scorcia
Journal:  Ophthalmol Ther       Date:  2020-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.